According to a market report by Lucintel, the future of the global Breast Biopsy Device market looks promising with opportunities in the hospital & clinic, research laboratory, and pharmaceutical & biotechnology markets. The global breast biopsy device market is expected to reach an estimated $2.1 billion by 2030 with a CAGR of 5.2% from 2024 to 2030. The major drivers for this market are growing incidence of breast cancer, significant use of this device to enable less intrusive techniques, and rising preference for liquid biopsy.

A more than 150 – page report is developed to understand Trends, opportunity and forecast in breast biopsy device market to 2030 by type (biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and others), procedure (needle breast biopsy, open surgical breast biopsy, and liquid breast biopsy), application (early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring), end use (hospitals & clinics, research laboratories, pharmaceutical & biotechnology companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)In this market, biopsy needle, guidance system, biopsy table, localization wire, assay kit, and liquid biopsy instrument are the major segments of breast biopsy device market by type. Lucintel forecasts that guidance system is expected to witness highest growth over the forecast period due to its significant use in enhancing the accuracy and efficiency of biopsy procedures.

Within this market, hospital will remain the largest segment due to the rising adoption of advanced diagnostic tools and skilled professionals to improve patient care in this setting.

North America is expected to witness highest growth over the forecast period due to rising breast cancer cases, availability of attractive reimbursement opportunities, and presence of robust healthcare infrastructure in the region.

Hologic, Danaher, Argon Medical Devices, Merit Medical Systems, Menarini-Silicon Biosystems, Guardant Health, NeoGenomics, Sysmex Inostics, Sterylab, and Biocept are the major suppliers in the breast biopsy device market.


This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected]